The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic
Open accessAbstract
Shigella is a major cause of morbidity, mortality, and growth retardation for children in developing countries. Emergence of antibiotic resistance among Shigellae demands the development of effective medicines. Previous studies found that the endogenous antimicrobial peptide LL-37 is down-regulated in the rectal epithelium of patients during shigellosis and that butyrate up-regulates the expression of LL-37 in colonic epithelial cells in vitro and decreases severity of inflammation in experimental shigellosis. In this study, Shigella -infected dysenteric rabbits were treated with butyrate (0.14 mmol/kg of body weight) twice daily for 3 days, and the expression levels of the rabbit homologue to LL-37, CAP-18, were monitored in the colon. Butyrate treatment resulted in ( i ) reduced clinical illness, severity of inflammation in the colon, and bacterial load in the stool, ( ii ) significant up-regulation of CAP-18 in the surface epithelium, and ( iii ) disappearance of CAP-18-positive cells in lamina propria. The active CAP-18 peptide was released in stool from its proform by butyrate treatment. In healthy controls, CAP-18 expression was localized predominantly to the epithelial surface of the colon. In infected rabbits, CAP-18 expression was localized to immune and inflammatory cells in the colon, whereas the ulcerated epithelium was devoid of CAP-18 expression. The combination of CAP-18 and butyrate was more efficient in killing Shigella in vitro than CAP-18 alone. Our findings indicate that oral butyrate treatment in shigellosis may be of clinical value because of induction of the endogenous cathelicidin CAP-18 in the colonic epithelium, stimulation of the release of the active peptide CAP-18, and promoting elimination of Shigella .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Defensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Shigella flexneri induces apoptosis in infected macrophages
Zychlinsky, A., Prevost, M. C., & Sansonetti, P. J. (1992) · Nature · doi:10.1038/358167a0 · Cited by 1,262
Kotloff, K. L., Winickoff, J. P., Ivanoff, B., Clemens, J. D., Swerdlow, D. L., Sansonetti, P. J., Adak, G. K., & Levine, M. M. (1999) · Europe PMC (PubMed Central) · Cited by 1,242
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., & Bevins, C. L. (2003) · Nature · doi:10.1038/nature01520 · Cited by 765
Absorption of Short-Chain Fatty Acids by the Colon
Ruppin, H., Bar-Meir, S., Soergel, K. H., Wood, C. M., & Schmitt, M. G. (1980) · Gastroenterology · doi:10.1016/s0016-5085(19)30508-6 · Cited by 736
Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., & Salcedo, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0325z.x · Cited by 578
Self-citationIslam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., & Gudmundsson, G. H. (2001) · Nature Medicine · doi:10.1038/84627 · Cited by 429
Self-citationSchauber, J. (2003) · Gut · doi:10.1136/gut.52.5.735 · Cited by 383
Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole
Mounier, J., Vasselon, T., Hellio, R., Lesourd, M., & Sansonetti, P. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.1.237-248.1992 · Cited by 318
Postsecretory Processing Generates Multiple Cathelicidins for Enhanced Topical Antimicrobial Defense
Murakami, M., Lopez-Garcia, B., Braff, M., Dorschner, R. A., & Gallo, R. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3070 · Cited by 308
Hase, K., Eckmann, L., Leopard, J. D., Varki, N., & Kagnoff, M. F. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.953-963.2002 · Cited by 293
Wassef, J. S., Keren, D. F., & Mailloux, J. L. (1989) · Infection and Immunity · doi:10.1128/iai.57.3.858-863.1989 · Cited by 277
The butyrate story: old wine in new bottles?
Scheppach, W., & Weiler, F. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200409000-00009 · Cited by 246
Vernia, P., Annese, V., Bresci, G., D’Albasio, G., D’Incà, R., Giaccari, S., Ingrosso, M., Mansi, C., Riegler, G., Valpiani, D., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01130.x · Cited by 217
Perdomo, J. J., Gounon, P., & Sansonetti, P. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117015 · Cited by 208
Sansonetti, P. J., Arondel, J., Cantey, J. R., Prévost, M. C., & Huerre, M. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2752-2764.1996 · Cited by 185
AGERBERTH, B., GRUNEWALD, J., CASTAÑOS-VELEZ, E., OLSSON, B., JÖRNVALL, H., WIGZELL, H., EKLUND, A., & GUDMUNDSSON, G. H. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9807041 · Cited by 165
Self-citationNeisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37
Bergman, P., Johansson, L., Asp, V., Plant, L., Gudmundsson, G. H., Jonsson, A., & Agerberth, B. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00530.x · Cited by 118
Self-citationRabbani, G. H., Albert, M. J., Rahman, A. S. M. H., Isalm, M. M., Islam, K. M. N., & Alam, K. (1999) · The Journal of Infectious Diseases · doi:10.1086/314584 · Cited by 58
Shigella dysenteriaeSerotype 1, Kolkata, India
Dutta, S., Dutta, D., Dutta, P., MATSUSHITA, S., Bhattacharya, S., & Yoshida, S. (2003) · Emerging infectious diseases · doi:10.3201/eid0911.020652 · Cited by 51
Sansonetti, P. J. (1998) · Folia Microbiologica · doi:10.1007/bf02818608 · Cited by 47
Cited by
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Short-chain fatty acids: Linking diet, the microbiome and immunity
Mann, E. R., Lam, Y. K., & Uhlig, H. H. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01014-8 · Cited by 1,595
SCFA: mechanisms and functional importance in the gut
Martin-Gallausiaux, C., Marinelli, L., Blottière, H. M., Larraufie, P., & Lapaque, N. (2021) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120006916 · Cited by 1,480
Regulation of immune cell function by short‐chain fatty acids
Corrêa‐Oliveira, R., Fachi, J. L., Vieira, A., Sato, F. T., & Vinolo, M. A. R. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.17 · Cited by 1,346
Microbial Regulation of Host Physiology by Short-chain Fatty Acids
van der Hee, B., & Wells, J. M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.001 · Cited by 980
Metadata
- Authors
- Raqib, R., Sarker, P., Bergman, P., Ara, G., Lindh, M., Sack, D. A., Nasirul Islam, K. M., Gudmundsson, G. H., Andersson, J., & Agerberth, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-06-13
- Volume
- 103
- Issue
- 24
- Pages
- 9178-9183
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2021800929
- Cited by
- 317
- References
- 25
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.